Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates-Reference-Cited by-同舟云学术

Study of immunogenicity and efficacy against Omicron BA.5 of recombinant protein-based COVID-19 vaccine delivered by intramuscular and mucosal routes in nonhuman primates

Published:2024-02 Issue:5 Volume:42 Page:1122-1135
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Pal Ranajit,Ferrari Maria Grazia,Honda-Okubo Yoshikazu^ORCID,Wattay Lauren,Caple Jesica,Navarrete Jennifer,Andersen Hanne,Petrovsky Nikolai^ORCID

Publisher

Elsevier BV

Reference51 articles.

1. World Health Organisation. Weekly operational update on COVID-19 -20 September 2021. 2021. p. 1-16.

2. Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England;Allen;Epidemiol Infect,2023

3. Evaluating the efficacy and safety of SpikoGen(R), an advax-CpG55.2-adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial;Tabarsi;Clin Microbiol Infect,2023

4. Editorial: First approval of the protein-based adjuvanted nuvaxovid (NVX-CoV2373) novavax vaccine for SARS-CoV-2 could increase vaccine uptake and provide immune protection from viral variants;Parums;Med Sci Monit,2022

5. Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with advax-SM adjuvant protects against COVID-19 infection;Li;Vaccine,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronavirus spike protein-based vaccines. Vaccine delivery systems;Medicine in Drug Discovery;2024-09

2. Post-Hoc Analysis of Potential Correlates of Protection of a Recombinant SARS-CoV-2 Spike Protein Extracellular Domain Vaccine Formulated with Advax-CpG55.2-Adjuvant;International Journal of Molecular Sciences;2024-08-30

3. Clinical development of SpikoGen®, an Advax-CpG55.2 adjuvanted recombinant spike protein vaccine;Human Vaccines & Immunotherapeutics;2024-06-05